Found: 41
Select item for more details and to access through your institution.
Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
A predictive nomogram for short‐term outcomes of myasthenia gravis patients treated with low‐dose rituximab.
- Published in:
- CNS Neuroscience & Therapeutics, 2024, v. 30, n. 5, p. 1, doi. 10.1111/cns.14761
- By:
- Publication type:
- Article
5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Targeted Complement Inhibitor CRIg/FH Protects Against Experimental Autoimmune Myasthenia Gravis in Rats via Immune Modulation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.746068
- By:
- Publication type:
- Article
Pneumonia in myasthenia gravis: Microbial etiology and clinical management.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.1016728
- By:
- Publication type:
- Article
Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1407418
- By:
- Publication type:
- Article
Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1326874
- By:
- Publication type:
- Article
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case series.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864241226745
- By:
- Publication type:
- Article
Short-term outcome prediction for myasthenia gravis: an explainable machine learning model.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231154976
- By:
- Publication type:
- Article
Short-term outcome prediction for myasthenia gravis: an explainable machine learning model.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, v. 16, p. 1, doi. 10.1177/17562864231154976
- By:
- Publication type:
- Article
Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopenia.
- Published in:
- Muscle & Nerve, 2024, v. 69, n. 6, p. 708, doi. 10.1002/mus.28092
- By:
- Publication type:
- Article
NOTCH2NLC‐related oculopharyngodistal myopathy type 3 with cardiomyopathy and nephropathy.
- Published in:
- Muscle & Nerve, 2023, v. 67, n. 5, p. E18, doi. 10.1002/mus.27808
- By:
- Publication type:
- Article
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 108, doi. 10.1177/1352458514535677
- By:
- Publication type:
- Article
Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.902384
- By:
- Publication type:
- Article
Clinical Features of Myasthenia Gravis With Antibodies to MuSK Based on Age at Onset: A Multicenter Retrospective Study in China.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.879261
- By:
- Publication type:
- Article
Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese Cohort.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.790941
- By:
- Publication type:
- Article
Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Low-dose rituximab every 6 months for the treatment of acetylcholine receptor-positive refractory generalized myasthenia gravis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Fatty infiltration evaluation and selective pattern characterization of lower limbs in limb-girdle muscular dystrophy type 2A by muscle magnetic resonance imaging.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Increased serum IL-2, IL-4, IL-5 and IL-12p70 levels in AChR subtype generalized myasthenia gravis.
- Published in:
- BMC Immunology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12865-022-00501-8
- By:
- Publication type:
- Article
Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1.
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-024-03114-z
- By:
- Publication type:
- Article
Diagnostic delay in late‐onset Pompe disease among Chinese patients: A retrospective study.
- Published in:
- Journal of Inherited Metabolic Disease Reports, 2024, v. 65, n. 1, p. 39, doi. 10.1002/jmd2.12404
- By:
- Publication type:
- Article
Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis.
- Published in:
- European Neurology, 2020, v. 83, n. 5, p. 500, doi. 10.1159/000510396
- By:
- Publication type:
- Article
Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
- Published in:
- European Neurology, 2020, v. 83, n. 2, p. 182, doi. 10.1159/000507853
- By:
- Publication type:
- Article
Predictive Score for In-Hospital Mortality of Myasthenic Crisis: A Retrospective Chinese Cohort Study.
- Published in:
- European Neurology, 2019, v. 81, n. 5/6, p. 287, doi. 10.1159/000503961
- By:
- Publication type:
- Article
Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04421-y
- By:
- Publication type:
- Article
Efgartigimod for generalized myasthenia gravis: A multicenter real‐world cohort study in China.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 8, p. 2212, doi. 10.1002/acn3.52142
- By:
- Publication type:
- Article
In‐depth peripheral CD4<sup>+</sup> T profile correlates with myasthenic crisis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 4, p. 749, doi. 10.1002/acn3.51312
- By:
- Publication type:
- Article
Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
- Published in:
- Rheumatology, 2017, v. 56, n. 2, p. 287, doi. 10.1093/rheumatology/kew386
- By:
- Publication type:
- Article
A Randomized Control Study on the Efficacy of Thymectomy in Patients with Nonthymomatous (without Chest Tumor) Myasthenia Gravis.
- Published in:
- Annals of Indian Academy of Neurology, 2020, v. 23, n. 1, p. 141, doi. 10.4103/aian.AIAN_138_19
- By:
- Publication type:
- Article
Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-term impact of nusinersen on motor and electrophysiological outcomes in adolescent and adult spinal muscular atrophy: insights from a multicenter retrospective study.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 9, p. 6004, doi. 10.1007/s00415-024-12567-y
- By:
- Publication type:
- Article
Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 9, p. 4288, doi. 10.1007/s00415-023-11759-2
- By:
- Publication type:
- Article
Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis.
- Published in:
- Journal of Neurology, 2017, v. 264, n. 11, p. 2191, doi. 10.1007/s00415-017-8616-7
- By:
- Publication type:
- Article
Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.
- Published in:
- Journal of Inherited Metabolic Disease, 2014, v. 37, n. 3, p. 399, doi. 10.1007/s10545-013-9671-6
- By:
- Publication type:
- Article
Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy.
- Published in:
- Neurology India, 2014, v. 62, n. 6, p. 635, doi. 10.4103/0028-3886.149386
- By:
- Publication type:
- Article
Molecular landscape of DYSF mutations in dysferlinopathy: From a Chinese multicenter analysis to a worldwide perspective.
- Published in:
- Human Mutation, 2021, v. 42, n. 12, p. 1615, doi. 10.1002/humu.24284
- By:
- Publication type:
- Article
Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1418503
- By:
- Publication type:
- Article
Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long‐term and low‐dose rituximab treatment for chronic inflammatory demyelinating polyneuropathy.
- Published in:
- Journal of the Peripheral Nervous System, 2024, v. 29, n. 3, p. 350, doi. 10.1111/jns.12653
- By:
- Publication type:
- Article